Issues in implementing lung cancer screening in United States and Europe

While recently the European lung cancer screening community published a position statement in order to promote the development in Europe of low-dose computed tomography (LDCT) lung cancer screening programmes (1), US Health Centers already began implementing lung cancer screening, and the article by Zeliadt et al. (2), reported the current state of the art of LDCT lung cancer screening in US Federally Qualified Health Centers. The authors focused on these types of clinics which predominantly serve low-socioeconomic populations, because of the suggestion of the Society of Behavioural Medicine which observed that disparities in lung cancer may be reduced implementing a high-quality lung cancer screening in high-risk populations (3).